Purchases and Sales Made in Q2 2024 in Innate Pharma Sa (IPHA)
This table provides information about the institutional ownership of Innate Pharma Sa (IPHA) during Q2 2024. The information is specifically focused on institutions that hold shares of Innate Pharma SA.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
23.5KNew |
$45.6K - $70.6K
|
23.5K
$45.2K
|
|
|
Aug 14, 2024
Q2 2024
|
Optiver Holding B.V.
Amsterdam, P7 |
BUY
|
- |
16.8K+ 23.79% |
$32.6K - $50.4K
|
87.4K
$168K
|
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
BUY
|
- |
87+ 41.43% |
$169 - $261
|
297
$570
|
|
|
Jul 23, 2024
Q2 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-600- 1.36% |
$1.16K - $1.8K
|
43.5K
$83.6K
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-600- 1.36% |
$1.16K - $1.8K
|
43.5K
$83.6K
|
|
|
Aug 13, 2024
Q2 2024
|
Exchange Traded Concepts, LLC
|
SELL
|
- |
-26.8K- 23.73% |
$52.1K - $80.5K
|
86.2K
$166K
|